{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:08:56Z","timestamp":1791274136100,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870079"],"award-info":[{"award-number":["81870079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["GMU2020-207"],"award-info":[{"award-number":["GMU2020-207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2021A050520012"],"award-info":[{"award-number":["2021A050520012"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["GMU2020-207"],"award-info":[{"award-number":["GMU2020-207"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.eclinm.2023.102100","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T16:25:24Z","timestamp":1689870324000},"page":"102100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Efficacy and safety of pharmacotherapy for refractory or unexplained chronic cough: a systematic review and network meta-analysis"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1711-6328","authenticated-orcid":false,"given":"Ziwen","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2855-4334","authenticated-orcid":false,"given":"Ziyuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuojia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyn","family":"Morice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Jung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eclinm.2023.102100_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01136-2019","article-title":"ERS guidelines on the diagnosis and treatment of chronic cough in adults and children","volume":"55","author":"Morice","year":"2020","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102100_bib2","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.00218714","article-title":"The global epidemiology of chronic cough in adults: a systematic review and meta-analysis","volume":"45","author":"Song","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eclinm.2023.102100_bib3","article-title":"Management of chronic refractory cough","volume":"351","author":"Gibson","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102100_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1378\/chest.15-1496","article-title":"Treatment of unexplained chronic cough: CHEST guideline and expert panel report","volume":"149","author":"Gibson","year":"2016","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102100_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/cpt.2003","article-title":"Mechanisms and rationale for targeted therapies in refractory and unexplained chronic cough","volume":"109","author":"Mazzone","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102100_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/atm.ATM_417_20","article-title":"Safety and efficacy of gefapixant, a novel drug for the treatment of chronic cough: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Abu-Zaid","year":"2021","journal-title":"Ann Thorac Med"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102100_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/14656566.2018.1462795","article-title":"An update and systematic review on drug therapies for the treatment of refractory chronic cough","volume":"19","author":"Ryan","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102100_bib8","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1164\/rccm.201704-0769OC","article-title":"XEN-D0501, a novel transient receptor potential vanilloid 1 antagonist, does not reduce cough in patients with refractory cough","volume":"196","author":"Belvisi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102100_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaci.2014.01.038","article-title":"Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial","volume":"134","author":"Khalid","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102100_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00269-2021","article-title":"Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough","volume":"7","author":"Ludbrook","year":"2021","journal-title":"ERJ Open Res"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102100_bib11","first-page":"143","article-title":"[Guidelines of the German respiratory society for diagnosis and treatment of adults suffering from acute, subacute and chronic cough]","volume":"73","author":"Kardos","year":"2019","journal-title":"Pneumologie"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102100_bib12","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1183\/09031936.00218613","article-title":"Expert opinion on the cough hypersensitivity syndrome in respiratory medicine","volume":"44","author":"Morice","year":"2014","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102100_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102100_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.alit.2022.05.006","article-title":"A\u00a0phase 3, randomized, double-blind, clinical study to evaluate the long-term safety and efficacy of gefapixant in Japanese adult participants with refractory or unexplained chronic cough","volume":"71","author":"Niimi","year":"2022","journal-title":"Allergol Int"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102100_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00725-2021","article-title":"Randomised trial of the P2X3 receptor antagonist sivopixant for refractory chronic cough","volume":"59","author":"Niimi","year":"2022","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102100_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01615-2019","article-title":"Gefapixant in two randomised dose-escalation studies in chronic cough","volume":"55","author":"Smith","year":"2020","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102100_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S2213-2600(19)30471-0","article-title":"Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial","volume":"8","author":"Smith","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.eclinm.2023.102100_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2023.102100_bib19","series-title":"Cochrane handbook for systematic reviews of interventions version 6.3","year":"2022"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102100_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions","volume":"64","author":"Brozek","year":"2009","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102100_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102100_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29581","article-title":"Comparison of treatments for frozen shoulder: a systematic review and meta-analysis","volume":"3","author":"Challoumas","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102100_bib23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"7414","key":"10.1016\/j.eclinm.2023.102100_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102100_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102100_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2023.102100_bib27","series-title":"Review manager (RevMan) [Computer program]. Version 5.3","year":"2014"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102100_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Res Synth Methods"},{"issue":"9974","key":"10.1016\/j.eclinm.2023.102100_bib29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(14)61255-1","article-title":"P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study","volume":"385","author":"Abdulqawi","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102100_bib30","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jaip.2020.11.037","article-title":"A\u00a0randomized controlled trial to assess the effect of lidocaine administered via throat spray and nebulization in patients with refractory chronic cough","volume":"9","author":"Abdulqawi","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102100_bib31","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00546-2021","article-title":"A\u00a0double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough","volume":"8","author":"Badri","year":"2022","journal-title":"ERJ Open Res"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102100_bib32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S2213-2600(17)30310-7","article-title":"A\u00a0novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial","volume":"5","author":"Birring","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102100_bib33","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.chest.2015.12.036","article-title":"The effects of azithromycin in treatment-resistant cough: a randomized, double-blind, placebo-controlled trial","volume":"149","author":"Hodgson","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102100_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00408-022-00592-5","article-title":"A\u00a0randomized, double-blind, placebo-controlled, parallel-group phase 2b trial of P2X3 receptor antagonist sivopixant for refractory or unexplained chronic cough","volume":"201","author":"McGarvey","year":"2023","journal-title":"Lung"},{"issue":"10328","key":"10.1016\/j.eclinm.2023.102100_bib35","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(21)02348-5","article-title":"Efficacy and safety of gefapixant, a P2X(3) receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials","volume":"399","author":"McGarvey","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102100_bib36","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04240-2020","article-title":"Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study","volume":"58","author":"Morice","year":"2021","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102100_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00439-2019","article-title":"The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study","volume":"54","author":"Morice","year":"2019","journal-title":"Eur Respir J"},{"issue":"9853","key":"10.1016\/j.eclinm.2023.102100_bib38","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(12)60776-4","article-title":"Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Ryan","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102100_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.chest.2019.08.001","article-title":"The neurokinin-1 receptor antagonist orvepitant is a novel antitussive therapy for chronic refractory cough: results from a phase 2 pilot study (VOLCANO-1)","volume":"157","author":"Smith","year":"2020","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102100_bib40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/thx.2010.142711","article-title":"Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial","volume":"65","author":"Yousaf","year":"2010","journal-title":"Thorax"},{"issue":"16","key":"10.1016\/j.eclinm.2023.102100_bib41","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMcp1414215","article-title":"Chronic cough","volume":"375","author":"Smith","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2023.102100_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11302-011-9271-6","article-title":"In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization","volume":"8","author":"Ford","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.eclinm.2023.102100_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/17534666211049743","article-title":"Validation of a visual analog scale for assessing cough severity in patients with chronic cough","volume":"15","author":"Martin Nguyen","year":"2021","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.eclinm.2023.102100_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-540-79842-2_16","article-title":"Clinical cough IV: what is the minimal important difference for the leicester cough questionnaire?","volume":"187","author":"Raj","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.eclinm.2023.102100_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pupt.2019.03.007","article-title":"BLU-5937: a selective P2X3 antagonist with potent anti-tussive effect and no taste alteration","volume":"56","author":"Garceau","year":"2019","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.eclinm.2023.102100_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2019.101835","article-title":"ATP cough challenge","volume":"58","author":"Morice","year":"2019","journal-title":"Pulm Pharmacol Ther"},{"issue":"5753","key":"10.1016\/j.eclinm.2023.102100_bib47","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1126\/science.1118435","article-title":"ATP signaling is crucial for communication from taste buds to gustatory nerves","volume":"310","author":"Finger","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102100_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s40136-019-00239-9","article-title":"Therapeutic targets for the treatment of chronic cough","volume":"7","author":"Roe","year":"2019","journal-title":"Curr Otorhinolaryngol Rep"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102100_bib49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaci.2015.10.044","article-title":"Transient receptor potential cation channel, subfamily V, member 4 and airway sensory afferent activation: role of adenosine triphosphate","volume":"138","author":"Bonvini","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102100_bib50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12931-019-1077-z","article-title":"Heterogeneity of cough hypersensitivity mediated by TRPV1 and TRPA1 in patients with chronic refractory cough","volume":"20","author":"Long","year":"2019","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102100_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/ph9030045","article-title":"TRPV1 and TRPM8 in treatment of chronic cough","volume":"9","author":"Millqvist","year":"2016","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102100_bib52","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1164\/rccm.200402-174OC","article-title":"Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough","volume":"170","author":"Groneberg","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102100_bib53","doi-asserted-by":"crossref","first-page":"L941","DOI":"10.1152\/ajplung.00366.2011","article-title":"TRPV1 induction in airway vagal low-threshold mechanosensory neurons by allergen challenge and neurotrophic factors","volume":"302","author":"Lieu","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102100_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rmed.2014.11.001","article-title":"Cough reduction using capsaicin","volume":"109","author":"Ternesten-Hass\u00e9us","year":"2015","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102100_bib55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-022-00370-w","article-title":"Cough hypersensitivity and chronic cough","volume":"8","author":"Chung","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102100_bib56","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.21037\/jtd.2016.10.51","article-title":"The efficacy of specific neuromodulators on human refractory chronic cough: a systematic review and meta-analysis","volume":"8","author":"Wei","year":"2016","journal-title":"J\u00a0Thorac Dis"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023002778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023002778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:01:43Z","timestamp":1778904103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023002778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":56,"alternative-id":["S2589537023002778"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102100","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of pharmacotherapy for refractory or unexplained chronic cough: a systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102100"}}